State of Tennessee, Treasury Department - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of Tennessee, Treasury Department ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,437,365
+18.1%
52,757
-3.6%
0.01%
+20.0%
Q2 2023$1,217,075
-19.0%
54,700
-21.1%
0.01%
-28.6%
Q1 2023$1,501,818
+101718.2%
69,336
-4.5%
0.01%0.0%
Q4 2022$1,475
-20.8%
72,6360.0%0.01%
-22.2%
Q3 2022$1,863
-99.9%
72,636
+12.5%
0.01%
+28.6%
Q2 2022$1,536,000
-11.3%
64,586
-16.0%
0.01%0.0%
Q1 2022$1,732,000
+14.8%
76,933
+1.0%
0.01%
+16.7%
Q4 2021$1,509,000
-0.7%
76,170
-1.2%
0.01%0.0%
Q3 2021$1,519,000
-2.4%
77,115
+9.0%
0.01%0.0%
Q2 2021$1,557,000
-2.9%
70,755
+4.9%
0.01%
-14.3%
Q1 2021$1,604,000
-8.9%
67,419
+0.2%
0.01%0.0%
Q4 2020$1,760,000
+66.0%
67,288
+10.5%
0.01%
+40.0%
Q3 2020$1,060,000
-1.0%
60,870
-4.4%
0.01%0.0%
Q2 2020$1,071,000
+36.1%
63,643
-3.8%
0.01%
+25.0%
Q1 2020$787,000
-19.6%
66,160
-18.2%
0.00%0.0%
Q4 2019$979,000
-18.6%
80,877
-4.9%
0.00%
-33.3%
Q3 2019$1,202,000
+47.1%
85,087
+16.1%
0.01%
+50.0%
Q2 2019$817,000
-17.5%
73,278
-13.1%
0.00%
-20.0%
Q1 2019$990,000
+1.9%
84,365
+16.0%
0.01%0.0%
Q4 2018$972,000
+7.8%
72,739
+13.1%
0.01%
+25.0%
Q3 2018$902,000
-12.3%
64,327
-1.6%
0.00%
-20.0%
Q2 2018$1,028,000
-7.6%
65,393
-3.4%
0.01%
-16.7%
Q1 2018$1,113,00067,6790.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders